Home/Filings/4/0001209191-10-000726
4//SEC Filing

Feeney John Joseph 4

Accession 0001209191-10-000726

CIK 0001347178other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 2:31 PM ET

Size

6.1 KB

Accession

0001209191-10-000726

Insider Transaction Report

Form 4
Period: 2010-01-01
Feeney John Joseph
Acting Chief Medical Officer
Transactions
  • Award

    Restricted Stock Units

    2010-01-01+30,00030,000 total
    Common Stock (30,000 underlying)
Footnotes (3)
  • [F1]The Restricted Stock Units represent a contingent right to receive a share of the Issuer's common stock.
  • [F2]The Restricted Stock Units vest in four equal annual installments beginning January 1, 2011. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
  • [F3]N/A

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001454240

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 2:31 PM ET
Size
6.1 KB